Looking to expand its molecular diagnostic portfolio, LabCorp (Burlington, N.C.) has agreed to acquire Monogram Biosciences (South San Francisco, Calif.), a manufacturer of pharmacogenomic tests or companion diagnostics. According to the merger agreement, LabCorp will acquire all outstanding shares of Monogram in a cash tender offer for $4.55 per share for an implied total equity value of approximately $106.7 million, or a total enterprise value of approximately $155 million, which includes net indebtedness. The deal is expected to close by the end of the third quarter.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

July 2009 - Table of Contents

LIR July 2009 (full PDF issue)

G-2 Reports-Chi Solutions’ Outreach Survey Indicates Labs Leading in Profitability Measures, Falling Short on Bad Debt and DSO

LabCorp Plans to Acquire Monogram Biosciences for Approximately $155 Million

Senate Bill Proposes ‘Date of Service’ Policy Change That Will Benefit Labs

Genoptix, Myriad Genetics Lead in G-2 Reports’ First Quarter Benchmarking Analysis

Psychemedics Teams With UK’s Bupa to Market Hair Analysis Assay

Inside the Lab Industry: Washington G-2 Reports-Chi Solutions’ Latest Survey Finds Outreach Lab Profitability Over 20% and Annual Revenue Growth Over 3%

The C-Suite Perspective: Building a Business Case for Outreach

Agendia Boosts MammaPrint Sales Effort Through CLIA Lab Launch, Sales Force Expansion

GE’s $100 Million Stimulus Simplicity Program to Offer No-Interest Loans for EMR Products

CBLPath Opens Manhattan Facility

Adeona Pharma Buys Chicago’s Hartlab to Expand Degenerative Disease Diagnostic Offerings

Lab Stocks Continue Impressive Show of Strength; Up 11% Over Five Weeks, 32% Over Past 13 Weeks

Industry Buzz: CDC Seeks Help in Establishing Laboratory Best Practices